TRAWNasdaqPharmaceutical PreparationsFiscal year ends December 31
Traws Pharma, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.37−0.00 (-0.76%)
Close on Oct 19, 2026
- Market cap
- $5.81M
- P/E (TTM)
- 0.4
- Dividend yield
- –
Traws Pharma statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Traws Pharma | Industry median |
|---|---|---|
| Market Cap | $5.63M | $163.01M |
| Enterprise Value | $616.47K | $86.72M |
Income (trailing twelve months)
| Measure | Traws Pharma | Industry median |
|---|---|---|
| Operating Income | -$21.54M | -$21.44M |
| Net Income | -$21.57M | -$22.46M |
| EBITDA | -$21.40M | -$16.91M |
Returns
| Measure | Traws Pharma | Industry median |
|---|---|---|
| Return on Assets (ROA) | -159.2% | -41.0% |
| Return on Capital Employed (ROCE) | -1241.7% | -37.8% |
Growth
| Measure | Traws Pharma | Industry median |
|---|---|---|
| Revenue Growth (3Y CAGR) | 131.1% | 2.25% |
| Revenue Growth (5Y CAGR) | 64.6% | 6.42% |
Balance sheet
| Measure | Traws Pharma | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $5.02M | $62.42M |
| Net Cash (Debt) | $5.02M | $15.68M |
| Net Cash Per Share | $0.33 | $0.66 |
| Working Capital | -$712.00K | $75.77M |
Financial position
| Measure | Traws Pharma | Industry median |
|---|---|---|
| Current Ratio | 0.93 | 3.30 |
| Quick Ratio | 0.87 | 2.39 |
Cash flow (trailing twelve months)
| Measure | Traws Pharma | Industry median |
|---|---|---|
| Operating Cash Flow | -$16.85M | -$12.35M |
Efficiency
| Measure | Traws Pharma | Industry median |
|---|---|---|
| Profits Per Employee | -$3.08M | -$703.34K |
| Employee Count | 7 | 74 |
Dividends and yields
| Measure | Traws Pharma | Industry median |
|---|---|---|
| Earnings Yield | -382.9% | -22.9% |
| Buyback Yield | -74.9% | -0.77% |
| Shareholder Yield | -74.9% | 0.00% |
Shares
| Measure | Traws Pharma | Industry median |
|---|---|---|
| Shares Outstanding | 15,368,300 | 58,179,650 |
| Shares Change (YoY) | 162.4% | 11.1% |
| Shares Change (QoQ) | 50.2% | 0.54% |
| Float | 9,886,070 | 49,173,100 |
| Shares Held by Insiders | 35.7% | 11.6% |
| Shares Held by Institutions | 40.1% | 59.4% |
Scores
| Measure | Traws Pharma | Industry median |
|---|---|---|
| Altman Z-Score | -85.28 | -0.28 |
| Piotroski F-Score | 4 | 4 |
Calculated by StockData from Traws Pharma's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.